Tenet Healthcare Corp (NYSE:THC) currently has a daily average trading volume of 1.60M but it saw 1342769 shares traded in last market. With a market cap of 15.78B USD, the company’s current market price of $169.89 came falling about -1.13 while comparing to the previous closing price of $171.84. In past 52 weeks, the stock remained buoying in the range of price level as high as $174.14 and as low as $109.82.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which upgraded the stock as “Overweight” in its note to investors issued on May 29, 2025, recommending a price target of $195 for it. Robert W. Baird downgraded its recommendation for the stock as a “Neutral” from “Outperform” on April 15, 2025 while assigning a price target of $137. Morgan Stanley issued its recommendations for the stock as it initiated the price target for the stock is $165.
Over the week, THC’s stock price is moving 3.17% up while it is 14.00% when we observe its performance for the past one month. Year-to-date it is 34.59% up and over the past year, the stock is showing an upside performance of 25.64%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of 2.86 while estimate for next year EPS is 12.82. In next quarter, company is expected to be making quarterly sales of $5.17B as analysts are expecting the sales for current fiscal year at $20.92B and seeing the company making $21.95B in sales next year. Moreover, analysts are in estimates of $5.16B for current-quarter revenue.
Currently, Tenet Healthcare Corp’s total number of outstanding shares is 92.89M with 0.74% of that held by the insiders while 99.30% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 8.43% and return on equity (ROE) at 38.12%. It has a price to earnings ratio (P/E ratio) of 11.23 while having a 12.42 of forward P/E ratio. Stock’s beta reads 1.67. Stock has a price to book (P/B) ratio of 3.77 while price to sale or P/S ratio amounts to 0.77. Its return on asset (ROA) is 5.00% on average.
